Search

Displaying all 2 results
  1. Pathway

    Ripretinib Action Pathway

    smpdb.ca/view/SMP0126912
    Drug action

    Ripretinib is a kinase inhibitor primarily used to treat advanced gastrointestinal stromal tumor (GIST) that has not responded well to other kinase inhibitors like sunitinib and imatinib. … Ripretinib's mechanism of action involves inhibiting protein kinases, including both wild type and mutant forms of platelet-derived growth factor receptor A (PDGFRA) and KIT, which are implicated in the

    Drugs: Calcium · Ripretinib
  2. Pathway

    Ripretinib Predicted Metabolism Pathway

    smpdb.ca/view/SMP0174724
    Metabolic

    Metabolites of Ripretinib are predicted with biotransformer.

    Drugs: Mesoheme · Ripretinib